col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Lung Cancer
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―19 An invisible group of COVID-19 victims; Impact on Dutch lung cancer care Jesper van Breeschoten, Rawa Ismail, Hans Smit, Olga Schuurbiers, Franz Schramel
2 [GO] 2021―Jul―16 Care Disruptions among Patients with Lung Cancer: A COVID-19 and Cancer Outcomes Study Sheena Bhalla, Ziad Bakouny, Andrew L. Schmidt, Chris Labaki, John A. Steinharter, Douglas A. Tremblay, et al. (+25)
3 [GO] 2021―May―28 Patient and physician opinion of virtual care in the oncology department of an Irish tertiary care centre in the era of Covid-19 Mary O’Reilly, Mark Doherty
4 [GO] 2021―May―28 Pneumomediastinum, lung cancer and Covid-19 Avinash Aujayeb
5 [GO] 2021―May―28 Stereotactic ablative body radiotherapy (SABR) lung fractionations locally in the COVID-19 era and the impact on dosimetry, resources, early toxicities, and the environment Lyndsey Phelps, Owen Morris, Nicole Dorey, Victoria Ford, Elizabeth Toy, Robert Biggar, Ian Fraser
6 [GO] 2021―May―28 Covid-19 in lung cancer patients in a DGH Avinash Aujayeb
7 [GO] 2021―May―28 The impact of COVID-19 on lung cancer diagnostics - a multicentre comparison of 2019/2020 data Neal Navani, Emma O’Dowd, Laura Succony, Berkay Karahacioglu, Robert Rintoul, Ian Woolhouse, et al. (+6)
8 [GO] 2021―May―28 Quantifying the impact of Covid-19 on lung cancer: an urgent need for restoration Emma O’Dowd, Laura Succony, Berkay Karahacioglu, Robert Rintoul, Ian Woolhouse, Matthew Evison, et al. (+6)
9 [GO] 2021―May―28 Impact of COVID-19 on mesothelioma clinical nurse specialists Bethany Taylor, Angela Tod, Clare Gardiner, Faye Forde, Lorraine Creech, Liz Darlison
10 [GO] 2021―May―28 The effect of COVID-19 on the presentation, staging, and treatment of lung cancer: a retrospective comparative audit of the ‘first wave’ Lisa Evetts, Laura Applegate, Amal Singh, Claire Johnson, Sian Wing, Bernadette McBride, et al. (+5)
11 [GO] 2021―May―28 ‘Your cough could be masking something else’ - raising awareness of lung cancer during the Covid-19 pandemic Aoife Mc Namara
12 [GO] 2021―May―28 Adapting lung cancer diagnostics during the Covid-19 pandemic Alex Bull
13 [GO] 2021―May―28 Lung cancer upstaging due to the COVID-19 pandemic Claire Vella, Asif Ashraf, Rajini Sudhir, Daniel Barnes, Jan Brozik, Praveen Rao, et al. (+12)
14 [GO] 2021―May―28 Lung cancer diagnosis: impact of the COVID-19 pandemic Sohail Ali, Rahul Dalal, Sharon Longden, Samuel Roberts, Michael Crawford
15 [GO] 2021―May―28 Anxiety and depression in lung cancer patients during Covid-19 pandemic Anitha Jacob, Rahul Mogal, Andrew Barlow, Rama Vancheeswaran
16 [GO] 2021―May―28 Evaluation of telephone consultations for follow up lung cancer patients at Royal Papworth Hospital, undertaken instead of face-to-face consultations during the Covid-19 pandemic Claire Haslop, Michael Bates, Lavinia Magee, Panagiota Chrysikaki
17 [GO] 2021―May―28 A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic Matt Church, Paul Taylor, Yvonne Summers, Raffaele Califano, Shereen Rafee, Mairead Dixon, et al. (+2)
18 [GO] 2021―May―28 Maintaining flexible bronchoscopy and endobronchial ultrasound (EBUS) services during the COVID-19 pandemic at a tertiary centre: the Manchester Royal Infirmary experience Eman Nasr, Durgesh Rana, Nadira Narine, Haider AL-Najjar
19 [GO] 2021―May―28 Use of single-agent pembrolizumab as first-line treatment for non-small cell lung cancer with PDL1 status 50% as per NHS England interim guidance during the COVID-19 pandemic at Southend University Hospital Rebecca Sen, Rafiqul Islam Islam, Harriet Baker, Samuel Kim
20 [GO] 2021―May―28 Analysis of the source of lung cancer diagnoses during 2020 COVID-19 pandemic compared with 2015-2019 in the York and Scarborough NHS Trust Hazel Watchorn
21 [GO] 2021―May―28 Impact of the Covid-19 pandemic on a District General Hospital EBUS service Matthew Wright, Raquel d’Espiney, Jack Mulholland, Malcolm Lawson
22 [GO] 2021―May―28 The impact of the COVID-19 pandemic on lung cancer diagnosis and stage at Plymouth NHS Trust Helen McDill, Maged Hassan, Lindsey Taylor, John Corcoran, Cyrus Daneshvar
23 [GO] 2021―May―28 The impact of the COVID-19 pandemic on patient advocacy and support organisations in the UK and Ireland - results from a Global Lung Cancer Coalition (GLCC) survey Lorraine Dallas, Aoife McNamara, Matthew Peters, Riddhi Thakrar
24 [GO] 2021―May―28 The impact of the COVID-19 pandemic on pleural activity at Plymouth NHS Trust Helen McDill, Maged Hassan, Hem Rai, Avik Ghoshal, Emma Graham, Lindsey Taylor, et al. (+2)
25 [GO] 2021―May―28 The impact of the COVID-19 pandemic on referrals and diagnoses of lung cancer in a tertiary hospital Jamie Arberry, Louis Dwyer Hemmings, Jessica Gates, Jennifer Ross, Adrian Draper, Yee-Ean Ong
26 [GO] 2021―May―28 The effects of the COVID-19 pandemic on the lung cancer service at Northwick Park Hospital (NWPH) Lavanya Anandan, Priya Ramachandran, Arnab Datta, Tarangini Sathyamoorthy
27 [GO] 2021―May―28 Impact of the COVID-19 pandemic on the use of systemic anti-cancer therapy for patients diagnosed with malignancy at thoracoscopy in Aneurin Bevan University Health Board Eleanor Barton, Alina Ionescu
28 [GO] 2021―May―28 Delivering bronchoscopy and respiratory diagnostic service for lung cancer during COVID-19 pandemic: a single-centre experience Sue-Lis Yeo, Syed Muneer-ahmed, Mohammed Haris, Muhammad Ganaie, Nadeem Maddekar, Ahmad AbimusaAsa’ari, et al. (+3)
29 [GO] 2021―May―28 No evidence of increased susceptibility to COVID-19 virus among radical lung radiotherapy patients Oskar Lepiarczyk, Jonathan McAleese
30 [GO] 2021―May―28 Lung nodule management in Covid-19: does postponed surveillance matter? Ratnaprashanthika Ratnakumar, Jocelyn Fraser, Rebecca Nicholls, Jennifer Quint, Susannah Bloch
31 [GO] 2021―May―28 Emergency presentation of lung cancer: did it increase during the COVID-19? Cai Lupei, Muhammad Tariq, Imran Hussain, Nadeem Maddekar, Shahul Leyakathali khan
32 [GO] 2021―May―28 Impact of the coronavirus pandemic and national lockdown on a lung cancer service - opportunities for innovation Puneet Malhotra, Amy McIntosh, Pauline Murphy, Victoria Peers
33 [GO] 2021―May―28 The impact of SARS-COV-2 pandemic on pleural services, diagnosis of malignant effusions and junior doctors’ procedural training Nathan Riddell, Artemio Gonzales, Alina Ionescu
34 [GO] 2021―May―28 Does the use of primary care spirometry results in patients referred with suspected lung cancer have potential to avoid delays in the lung cancer referral pathway as a result of the SARS-COV-2 pandemic? Romy Ni Chleirigh, Joshua Macarthur, Sarah MacRae
35 [GO] 2021―May―28 Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung) Kathryn Banfill Banfill, Gareth Price, Kate Wicks, Shahreen Ahmad, Hannah Bainbridge, Mike Bayne, et al. (+24)
36 [GO] 2021―May―28 Lung cancer treatment during a pandemic: how have multi-disciplinary teams changed? James Hargrave, Claire Hastings, Jackie Fenemore, Lorraine Dallas, Tom Newsom-Davis, Robert Rintoul
37 [GO] 2021―May―14 Lung Cancer Patients with COVID-19 in Spain: GRAVID study Mariano Provencio, José María Mazarico Gallego, Antonio Calles, Mónica Antoñanzas, Cristina Pangua, Xabier Mielgo Rubio, et al. (+22)
38 [GO] 2021―May―08 Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral center Clémence Basse, Catherine Daniel, Alain Livartowski, Sophie Beaucaire-Danel, Nicolas Girard
39 [GO] 2021―May―05 Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis Haike Lei, Yue Yang, Wei Zhou, Mengyang Zhang, Yang Shen, Dan Tao, et al. (+4)
40 [GO] 2021―Apr―30 Safety monitoring of 2 and 4-weekly adjuvant durvalumab for patients with Stage III NSCLC; implications for the COVID-19 pandemic and beyond Kroopa Joshi, Abdul Muhith, Mariam Obeid, Charlotte Milner-Watts, Nadia Yousaf, Sanjay Popat, et al. (+4)
41 [GO] 2020―Dec―24 Evaluation of variant frequency in SARS-CoV-2 infection-related genes utilizing lung cancer genomic database Yuji Shibata, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
42 [GO] 2020―Dec―16 Cancer treatment in the coronavirus disease pandemic Jia-Tao Zhang, Wen-Zhao Zhong, Yi-Long Wu
43 [GO] 2020―Jun―17 Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic Hsu-Liang Chang, Po-Ju Wei, Kuan-Li Wu, Hung-Ling Huang, Chih-Jen Yang
44 [GO] 2020―Jun―12 The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2 Kai Wang, Yang Liu, Tian Hu, Yumei Liu, Chao Liu
45 [GO] 2020―May―30 Covid-19 and lung cancer: A greater fatality rate? Jacobo Rogado, Cristina Pangua, Gloria Serrano-Montero, Berta Obispo, Almudena Martín Marino, Mar Pérez-Pérez, et al. (+3)
46 [GO] 2020―May―26 Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak Zhongxing Liao, Eleonor Rivin del Campo, Ahmed Salem, Qingsong Pang, Hui Liu, Jose Luis Lopez Guerra
47 [GO] 2020―May―11 Immune checkpoint inhibitors in SARS-COV-2 infected cancer patients: the spark that ignites the fire? Vincenzo Di Noia, Alessandro D’Aveni, Michela Squadroni, Giordano Berett, Giovanni Luca Ceresoli
48 [GO] 2020―May―06 Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience David Rossi
49 [GO] 2020―May―04 A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? María Sereno, Gerardo Gutiérrez-Gutiérrez, Carmen Sandoval, Sandra Falagan, Ana María Jimenez-Gordo, María Merino, et al. (+4)


Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.011 sec